Preeclampsia and pregnancies achieved by in vitro fertilization, are they related?
DOI:
https://doi.org/10.51481//amc.v67i1.1401Keywords:
Preeclampsia, in vitro fertilization, reproduction, aspirinAbstract
The use of assisted reproduction techniques such as in vitro fertilization has been increasing in recent decades, with up to 8 million newborns conceived this way since 1978, when the first person conceived by this methods was born. Assisted reproduction has been associated with an increase in the incidence of multiple obstetric and perinatal complications such as preeclampsia. This article presents a narrative review of the association between in vitro fertilization and preeclampsia, with the most commonly associated maternal factors and procedure, along with measures that have been proposed to reduce this risk.
Downloads
References
1. Eskew AM, Jungheim ES. A history of developments to improve in vitro fertilization. Mo Med 2017; 114:156-159.
2. Wade JJ, MacLachlan V, Kovacs G. The success rate of IVF has significantly improved over the last decade. Aust N Z J Obstet Gynaecol. 2015; 55:473-476. DOI: 10.1111/ajo.12356
3. Gui J, Ling Z, Hou X, Fan Y, Xie K, Shen R. In vitro fertilization is associated with the onset and progression of preeclampsia. Placenta. 2020; 89:50-57. DOI: 10.1016/j.placenta.2019.09.011
4. Wang Z, Liu H, Song H, Li X, Jiang J, Shen Y, et al. Increased risk of pre-eclampsia after frozen-thawed embryo transfer in programming cycles. Front Med. 2020;7:104. DOI: 10.3389/fmed.2020.00104
5. Dall’Agnol H, García Velasco JA. Frozen embryo transfer and preeclampsia: where is the link? Curr Opin Obstet Gynecol. 2020; 32:213-218. DOI: 10.1097/GCO.0000000000000624
6. Roelens C, Blockeel C. Impact of different endometrial preparation protocols before frozen embryo transfer on pregnancy outcomes: a review. Fertil Steril. 2022;118:820-827. DOI: 10.1016/j.fertnstert.2022.09.003
7. Von Versen-Höynck F, Schaub AM, Chi YY, Chiu KH, Liu J, Lingis C, et al. Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. 2019; 73:640-649. DOI: 10.1161/HYPERTENSIONAHA.118.12043
8. Penzias A, Azziz R, Bendikson K, Falcone T, Hansen K, Hill M, et al. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114:1151-1157. DOI: 10.1016/j.fertnstert.2020.09.134
9. Moolhuijsen LME, Visser JA. Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020; 105:3361-3373. DOI: 10.1210/clinem/dgaa513
10. Zhang Y, Xu Y, Xue Q, Shang J, Yang X, Shan X, et al. Discordance between antral follicle counts and anti-Müllerian hormone levels in women undergoing in vitro fertilization. Reprod Biol Endocrinol. 2019; 17:51. DOI: 10.1186/s12958-019-0497-4
11. Younis JS, Ben-Ami M, Ben-Shlomo I. The Bologna criteria for poor ovarian response: a contemporary critical appraisal. J Ovarian Res. 2015;8:76. DOI: 10.1186/s13048-015-0204-9
12. Ganer Herman H, Volodarsky-Perel A, Ton Nu TN, Machado-Gedeon A, Cui Y, Shaul J, et al. Diminished ovarian reserve is a risk factor for preeclampsia and placental malperfusion lesions. Fertil Steril. 2023; 119:794-801. DOI: 10.1016/j.fertnstert.2023.01.029
13. Rodriguez-Wallberg K, Berger A, Fagerberg A, Olofsson J, Scherman-Pukk C, Lindqvist P, et al. Increased incidence of obstetric and perinatal complications in pregnancies achieved using donor oocytes and single embryo transfer in young and healthy women: a prospective hospital-based matched cohort study. Gynecol Endocrinol. 2019; 35:152-157 DOI: 10.1080/09513590.2018.1528577
14. Kenny LC, Kell DB. Immunological tolerance, pregnancy, and preeclampsia: the roles of semen microbes and the father. Front Med. 2018; 4:239. DOI: 10.3389/fmed.2017.00239
15. Okby R, Harlev A, Sacks KN, Sergienko R, Sheiner E. Preeclampsia acts differently in in vitro fertilization versus spontaneous twins. Arch Gynecol Obstet. 2018; 297:653-658. DOI: 10.1007/s00404-017-4635-y
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
